Barclays PLC Has $208,000 Stake in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Barclays PLC raised its holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 449.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 101,953 shares of the company’s stock after acquiring an additional 83,412 shares during the period. Barclays PLC’s holdings in Stereotaxis were worth $208,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in STXS. Renaissance Technologies LLC grew its stake in Stereotaxis by 46.2% in the second quarter. Renaissance Technologies LLC now owns 488,700 shares of the company’s stock valued at $889,000 after acquiring an additional 154,400 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of Stereotaxis by 247.5% in the second quarter. Bank of New York Mellon Corp now owns 189,592 shares of the company’s stock valued at $345,000 after purchasing an additional 135,041 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Stereotaxis by 7.2% in the third quarter. Geode Capital Management LLC now owns 1,391,718 shares of the company’s stock valued at $2,840,000 after purchasing an additional 93,253 shares in the last quarter. Rhumbline Advisers lifted its holdings in shares of Stereotaxis by 645.6% in the second quarter. Rhumbline Advisers now owns 48,251 shares of the company’s stock valued at $88,000 after purchasing an additional 41,780 shares in the last quarter. Finally, State Street Corp lifted its holdings in shares of Stereotaxis by 5.7% in the third quarter. State Street Corp now owns 680,612 shares of the company’s stock valued at $1,388,000 after purchasing an additional 36,518 shares in the last quarter. 45.35% of the stock is owned by institutional investors and hedge funds.

Stereotaxis Stock Performance

Shares of Stereotaxis stock opened at $2.17 on Wednesday. The stock has a market capitalization of $183.86 million, a PE ratio of -7.75 and a beta of 1.55. Stereotaxis, Inc. has a one year low of $1.66 and a one year high of $3.29.

Stereotaxis (NYSEAMERICAN:STXS) last issued its quarterly earnings results on Monday, November 11th. The company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). Stereotaxis had a negative net margin of 85.79% and a negative return on equity of 162.54%. The firm had revenue of $9.20 million during the quarter, compared to the consensus estimate of $6.80 million. Analysts predict that Stereotaxis, Inc. will post -0.26 earnings per share for the current fiscal year.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.